Cunning Capital Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.02M Hold
19,031
2.05% 14
2025
Q4
$3.91M Hold
19,031
1.81% 14
2025
Q3
$2.99M Hold
19,031
1.38% 25
2025
Q2
$3.2M Hold
19,031
1.67% 21
2025
Q1
$2.62M Sell
19,031
-109
-0.6% -$13.9K 1.67% 23
2024
Q4
$2.26M Hold
19,140
1.36% 28
2024
Q3
$2.12M Hold
19,140
1.11% 35
2024
Q2
$1.88M Hold
19,140
1.05% 35
2024
Q1
$2.14M Hold
19,140
1.19% 28
2023
Q4
$1.93M Hold
19,140
1.2% 26
2023
Q3
$1.66M Buy
+19,140
New +$1.73M 1.09% 37
2023
Q2
Sell
-19,140
Closed -$1.62M 30
2023
Q1
$1.45M Hold
19,140
0.98% 60
2022
Q4
$1.47M Sell
19,140
-7,660
-29% -$582K 1.04% 53
2022
Q3
$1.79M Hold
26,800
1.42% 20
2022
Q2
$1.4M Buy
+26,800
New +$1.52M 1.08% 51

Other funds holding CAH

Cunning Capital Partners's CAH Position: Q1 2026 in Review

Cunning Capital Partners held its Cardinal Health (CAH) position steady in Q1 2026 at 19,031 shares worth $4.02M. The position accounts for 2.05% of the portfolio, ranked #14.

Cunning Capital Partners first reported a position in CAH in Q2 2022 and has held it in 15 quarters since. 1,425 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Cunning Capital Partners held 19,031 shares of Cardinal Health worth $4.02M as of Q1 2026.
  • Cunning Capital Partners left its Cardinal Health share count unchanged in Q1 2026.
  • Cardinal Health made up 2.05% of Cunning Capital Partners's portfolio in Q1 2026, its #14 holding.
  • Cunning Capital Partners first reported a position in Cardinal Health in Q2 2022 and has held it in 15 quarters since.
  • 1,425 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Cunning Capital Partners's 13F filing for Q1 2026, filed 13 May 2026.